Results of surgical and combined treatment for nonsmall cell lung cancer with postoperative radiation therapy in a mode of hypofranctionation. Post II. Relapse-free survival and survival without locoregional recurrence
Vol. 62 No. 1 (2016), Articles
Vol. 62 No. 1 (2016)

Results of surgical and combined treatment for nonsmall cell lung cancer with postoperative radiation therapy in a mode of hypofranctionation. Post II. Relapse-free survival and survival without locoregional recurrence

Articles
https://doi.org/10.37469/0507-3758-2016-62-1-72-78
Published 15.12.2016
Russian Research Center of Rentgenoradiology
Russian Research Center of Rentgenoradiology
Russian Research Center of Rentgenoradiology
Russian Research Center of Rentgenoradiology
Russian Research Center of Rentgenoradiology
Russian Research Center of Rentgenoradiology
Russian Research Center of Rentgenoradiology
##article.numberofdownloads## 27
##article.numberofviews## 87
PDF (Русский)

Keywords

non-small cell lung cancer
surgical treatment
postoperative radiation therapy

How to Cite

, , , , , , & . (2016). Results of surgical and combined treatment for nonsmall cell lung cancer with postoperative radiation therapy in a mode of hypofranctionation. Post II. Relapse-free survival and survival without locoregional recurrence. Voprosy Onkologii, 62(1), 72–78. https://doi.org/10.37469/0507-3758-2016-62-1-72-78
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Abstract

Conducting postoperative radiotherapy in a mode of hypofranctionation with SFD-3Gy to TFD-36-39Gy (EQD2 = 43,246,8Gy) in combined treatment of patients with non-small cell lung cancer allows significantly increasing a 5-year disease-free survival at IIB-IIIB stages of the disease (pN1-2) as well as the central cancer, squamous cell morphological type of tumor after surgery in a volume of lob-bilobectomy. The clearest effect of postoperative radiotherapy is assessed by survival without locoregional recurrence where radiation therapy in the adjuvant setting allows achieving a statistically significant increase in local control of the disease to the level of 85-95% regardless of stage of the disease, tumor size, regional lymph nodes lesion and the surgical treatment.
https://doi.org/10.37469/0507-3758-2016-62-1-72-78
##article.numberofdownloads## 27
##article.numberofviews## 87
PDF (Русский)

References

Миллер С.В., Тузиков С.А., Завьялов А.А. и др. Анализ осложнений комбинированного лечения немелкоклеточного рака легкого // Сиб. онкол. журнал. - 2007. - Т. 4. - C. 50-56.

Харченко В.П., Чхиквадзе В.Д. Хирургическое и комбинированное лечение немелкоклеточного рака легкого // Вопр. онкол. - 2009. - Т. 55. - № 4. - С. 455-458.

Черных А.В. Непосредственные результаты хирургического лечения немелкоклеточного рака легкого // Научно-медицинский вестник Центрального Черноземья. - 2007. - Т. 30. - С.45-47.

Черных А.В., Агафонова Л.В. Обоснование систематической медиастинальной билатеральной лимфодиссекции в хирургическом лечении немелкоклеточного рака легкого // Вестн. эксперимент. и кл. хирург. -2010. - Т. 3. - С. 129-132.

Bütof R., Kirchner K., Appold S. et al. Potential clinical predictors of outcome after postoperative radiotherapy of non-small cell lung cancer // Strahlenther Onkol. - 2014. - Vol. 190. - № 3. - P. 263-269.

Compton C.C., Byrd D.R., Garcia-Aguilar J. et al. AJCC Cancer Staging Atlas: A Companion to the Seventh Editions of the AJCC Cancer Staging Manual and Handbook: 2nd ed. Chicago. - 2012. - P. 318.

Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC) // Int. J. Rad. Oncol. Biol. Phys. - 1995. - Vol. 31. - № 5. - P. 1341-1346.

Feng W., Fu X.L., Cai X.W. et al. Patterns of local-regional failure in completely resected stage IIIA(N2) non-small cell lung cancer cases: implications for postoperative radiation therapy clinical target volume design // Int J Radiat Oncol Biol Phys. - 2014. - Vol. 88. - № 5. - P. 1100-1107.

Higgins K.A., Chino J.P., Berry M. et al. Local failure in resected N1 lung cancer: implications for adjuvant therapy // Int J Radiat Oncol Biol Phys. - 2012. - Vol. 83. - № 2. - P. 727-733.

Karakoyun-celik O., Yalman D., Bolukbasi Y et al. Postoperative radiotherapy in the management of resected non-small-cell lung carcinoma: 10 years’ experience in a single institute // Int. J. Radiation Oncology Biol. Phys. -2010. - Vol. 76. - № 2. - P. 433-439.

Kelsey C.R., Higgins K.A., Peterson B.L. et al. Local recurrence after surgery for non-small cell lung cancer: a recursive partitioning analysis of multi-institutional data // J Thorac Cardiovasc Surg. - 2013. - Vol. 146. - № 4. - P. 768-773.

Kepka L., Bujko K., Orlowski T. M. et al. Cardiopulmonary morbidity and quality of life in non-small cell lung cancer patients treated with or without postoperative radiotherapy // Radiotherapy and Oncology. - 2011. - Vol. 98. - P. 238-243.

Koike T., Koike T., Yoshiya K. et al. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer // J Thorac Cardiovasc Surg. - 2013. - Vol. 146. - № 2. - P. 372-378.

Kolodziejczyk M., Bujko K., Michalskb W., Kepka L. Incidence of isolated nodal failure in non-small cell lung cancer patients included in a prospective study of the value of PET-CT // Radiotherapy and Oncology. - 2012. - Vol. 104. - № 1. - P. 58-61.

Krupitskaya Y, Loo B.W. Jr. Post-operative radiation therapy (PORT) in completely resected non-small-cell lung cancer // Curr Treat Options Oncol. - 2008. - Vol. 9. - № 4-6. - P. 343-356.

Machtay M., Lee J.H.,. Shrager J.B. et al. Risk of Death From Intercurrent Disease Is Not Excessively Increased by Modern Postoperative Radiotherapy for High-Risk Resected Non-Small-Cell Lung Carcinoma // Journal of Clinical Oncology. - 2001.- Vol. 19. - P. 3912-3917.

Ohguri T, Yahara K., Moon S.D. et al. Postoperative radiotherapy for incompletely resected non-small cell lung cancer: clinical outcomes and prognostic value of the histological subtype // J. Radiat. Res. - 2012. - Vol. 53. - № 2. - P. 319-325.

Reyes D., Pienta K. The biology and treatment of oligometastatic cancer // Oncotarget. - 2015. -Vol. 6. -№ 11. - Р. 8491-8524.

Rosenman J.G., Liyi X., Lawrence B.M. Selective elective nodal irradiation: ‘‘let’s head ‘em offat the pass’’ // Int. J. Radiation Oncology Biol. Phys. - 2011. - Vol. 81. - № 5. - P. 1208-1210.

Saynak M., Veeramachaneni N.K., Hubbs J.L. et al. Local failure after Complete resection of “Early-Stage” non-small cell lung cancer: The potential role of post-operative radiation therapy // Lung cancer. - 2011. - Vol. 71. - P. 156-165.

Stojiljkovic D., Santrac N., Stojiljkovic T. et al. Correlation of tumor size as independent factor and disease stage with local recurrence of non-small cell lung carcinoma and its operability // J BUON. - 2015. - Vol. 20. - № 1. - P. 166-172.

van den Berg L.L., Klinkenberg T.J., Groen H.J., Widder J. Patterns of Recurrence and Survival after Surgery or Stereotactic Radiotherapy for Early Stage NSCLC // J Thorac Oncol. - 2015. - Vol. 10. - № 5. - P. 826-831.

Varlotto J.M., Recht A., Flickinger J.C. et al. Varying recurrence rates and risk factors associated with different definitions of local recurrence in patients with surgically resected, stage I nonsmall cell lung cancer // Cancer. -2010. - Vol. 116. - № 10. - P. 2390-2400.

Yano T., Okamoto T., Fukuyama S., Maehara Y Therapeutic strategy for postoperative recurrence in patients with nonsmall cell lung cancer // World J Clin Oncol. - 2014. -Vol. 5. - № 5. - Р. 1048-1054.

Yano T., Okamoto T., Haro A. et al. Local treatment of oligometastatic recurrence in patients with resected nonsmall cell lung cancer // Lung Cancer. - 2013. - Vol. 82. - № 3. - P. 431-435.

Zou B., Xu Y, Li T. et al. A multicenter retrospective analysis of survival outcome following postoperative chemoradiotherapy in non-small-cell lung cancer patients with N2 nodal disease // Int. J. Radiat. Oncol. Biol. Phys. - 2010. - Vol. 77. - №2. - P. 321-328.

All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...